Biochemical markers in risk stratification and diagnosis of acute coronary syndromes

Laboratory Medicine

Volumn 33, Issue 1, 2002, Pages 42-53

  Ogedegbe, H O ^a  

^a FLORIDA GULF COAST UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; BRAIN ENZYME; C REACTIVE PROTEIN; CARBONATE DEHYDRATASE; CREATINE KINASE MB; FATTY ACID BINDING PROTEIN; FIBRIN; GLYCOGEN PHOSPHORYLASE; HOMOCYSTEINE; ISOENZYME; LACTATE DEHYDROGENASE; MYOGLOBIN; PADGEM PROTEIN; SERUM AMYLOID A; TROPONIN;

ENZYME ANALYSIS; ENZYME RELEASE; HEART MUSCLE ISCHEMIA; HUMAN; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN SECRETION; RISK ASSESSMENT; SHORT SURVEY; THORAX PAIN;

EID: 0036135128     PISSN: 00075027     EISSN: None     Source Type: Journal    
DOI: 10.1309/AA7V-PRPU-CE90-UF36     Document Type: Short Survey

References (78)

1. National Academy of Clinical Biochemistry Standards of Laboratory Practice: Recommendations for the use of cardiac markers in coronary artery diseases
2. Biochemical markers of the acute coronary syndromes
3. Acute myocardial infarction and coronary reperfusion: Serum cardiac markers for the 1990s
4. Creatine kinase determination as early marker for the diagnosis of acute myocardial infarction
5. Early diagnosis of myocardial infarction by time sequential enzyme measurements
6. The potential utility of a rapid CK-MB assay in evaluating emergency department patients with possible myocardial infarction
7. Serum enzymes and isoenzymes in the diagnosis and differential diagnosis of myocardial ischemia and necrosis
8. Use of cardiac enzymes identifies patients with acute myocardial infarction otherwise unrecognized in the emergency department
9. Fundamentals of Clinical Chemistry. 5th ed.
10. Cardiac and Muscle Disease
11. Use of biochemical markers in acute coronary syndromes: IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage
12. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: Executive summary and recommendations a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina)
13. Cardiac troponins I and T in patients with suspected acute coronary syndrome: A comparative study in a routine setting
14. Is a more efficient operative strategy feasible for the emergency management of the patient with acute chest pain?
15. Chest pain centers: Diagnosis of acute coronary syndromes
16. Litigation against the emergency physician: Common features in cases of missed myocardial infarction
17. Improved detection of minor ischemic myocardial injury with measurement of serum cardiac troponin I
18. Accident and emergency medicine
19. Creatine kinase-MB isoenzyme adaptations in stressed human skeletal muscle of marathon runners
20. Early release from myocardial cells is not due to irreversible cell damage
21. Differentiating muscle damage from myocardial injury by means of the serum creatine kinase (CK) isoenzyme MB mass measurement/total CK activity ratio
22. Clinical and analytical evaluation of kits for measurement of creatine kinase isoenzyme MB
23. Early diagnosis of acute myocardial infarction based on assay for subforms of creatine kinase-MB
24. Sensitive, rapid assay of subforms of creatine kinase MB in plasma
25. Critical Difference between serial measurements of CKMB mass to detect myocardial damage
26. Biochemical markers of myocardial injury: Is MB creatine kinase the choice for the 1990s?
27. Cardiac biomarkers: Past, present, and future
28. Carbonic anhydrase III: The phosphatase activity is extrinsic
29. Carbonic anhydrase isozymes in the human pancreas
30. Serum carbonic anhydrase III and myoglobin concentrations in acute myocardial infarction
31. Biochemical markers of myocardial injury during cardiac operations
32. Clinical Chemistry, Principles, Procedures, Correlations
33. Cardiac troponin T composition in normal and regenerating human skeletal muscle
34. Correlation of antemortem serum creatine kinase, creatine kinase-MB, troponin I, and troponin T with cardiac pathology
35. Usefulness of serum troponin T levels on day three or four in predicting survival after acute myocardial infarction
36. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection
37. To T or not to T, that is the question
38. Cardiac troponin-I accurately predicts myocardial injury in renal failure
39. Cardiac troponins in patients with renal dysfunction
40. Comparison of two cardiac troponin T assays and one troponin I assay in patients with end stage renal failure
41. Circulating vascular cell adhesion molecule-I correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-I, E-selectin, P-selectin, and thrombomodulin
42. Soluble P-selectin and the risk of future cardiovascular events
43. Adhesion molecules in different treatments of acute myocardial infarction
44. Increased levels of soluble adhesion molecules, E-selectin and P-selectin, in patients with infective endocarditis and embolic events
45. Direct viewing of atherosclerosis in vivo: Plaque invasion by leukocytes is initiated by the endothelial selectins
46. Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction
47. Role of heart-type fatty acid-binding protein in early detection of acute myocardial infarction
48. Cardiac markers protocols in a chest pain observation unit
49. Oxidative stress and homocysteine in coronary artery disease
50. Influence of age and aex and day-to-day and within-day biological variation on plasma concentrations of fatty acid-binding protein and myoglobin in healthy subjects
51. Fatty acid-binding protein and the early detection of acute myocardial infarction
52. Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis
53. Prevention of myocardial infarction by vitamin B6
54. Accurate and rapid "multiplex heteroduplexing" method for genotyping key enzymes involved in folate/homocysteine metabolism
55. Influence of vitamin-optimized plasma homocysteine cutoff values on the prevalence of hyperhomocysteinemia in healthy adults
56. Lipids, lipoproteins and apolipoproteins and their disease associations
57. Angina
58. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly
59. Evaluation of four automated high-sensitivity c-reactive protein methods: Implications for clinical and epidemiological applications
60. Variability in the measurement of c-reactive protein in healthy subjects: Implications for reference intervals and epidemiological applications
61. High-sensitivity C-reactive protein: A novel and promising marker of coronary heart disease
62. Elevated creactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease
63. Periodontal infections contribute to elevated systemic C-reactive protein level
64. Unstable angina and elevated c-reactive protein levels predict enhanced vasoreactivity of the culprit lesion
65. Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention
66. C-reactive protein and cardiac troponin T in risk stratification: Differences in optimal timing of tests early after the onset of chest pain
67. Inflammatory markers in men with angiographically documented coronary heart disease
68. Cost-effectiveness of cardiac troponin I in a systematic chest pain evaluation protocol: Use of cardiac troponin I lowers length of stay for low-risk cardiac patients
69. Effective resource management using a clinical and laboratory algorithm for chest pain triage
70. Medicolegal aspects of acute myocardial infarction
71. Emergency department triage strategies for acute chest pain using creatine kinase-MB and troponin I assays: A costeffectiveness analysis
72. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction
73. Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I